Live feed
Filing
SC 13G
SC 13G0001535610-23-000014·Scinai Immunotherapeutics Ltd.
Schedule 13G ownership disclosure
BIONDVAX PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 09073Q105
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 228,329
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-23-000014
- Form type
- SC 13G
- Filer
- Scinai Immunotherapeutics Ltd.
- CIK
- CIK 1611747
- Filed
- Jan 04, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership